Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 26.96 CNY -3.54%
Market Cap: 6.4B CNY
Have any thoughts about
Sirio Pharma Co Ltd?
Write Note
Sirio Pharma Co Ltd
/
Income Statement
/
Cost of Revenue

Sirio Pharma Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sirio Pharma Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Cost of Revenue
-¥2.5B
CAGR 3-Years
-21%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Cost of Revenue
-¥15.2B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Cost of Revenue
-¥2B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Cost of Revenue
-¥3.3B
CAGR 3-Years
-28%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Cost of Revenue
-¥2.9B
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Cost of Revenue
-¥577m
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sirio Pharma Co Ltd
Glance View

Market Cap
6.4B CNY
Industry
Consumer products

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
35.1 CNY
Undervaluation 23%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Sirio Pharma Co Ltd's Cost of Revenue?
Cost of Revenue
-2.5B CNY

Based on the financial report for Dec 31, 2023, Sirio Pharma Co Ltd's Cost of Revenue amounts to -2.5B CNY.

What is Sirio Pharma Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-19%

Over the last year, the Cost of Revenue growth was -44%. The average annual Cost of Revenue growth rates for Sirio Pharma Co Ltd have been -21% over the past three years , -19% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.